Charles Schwab’s Praxis Precision Medicines PRAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $69.4M | Buy |
215,447
+17,146
| +9% | +$5.3M | 0.01% | 936 |
|
|
2025
Q4 | $58.4M | Buy |
198,301
+36,640
| +23% | +$6.82M | 0.01% | 1053 |
|
|
2025
Q3 | $8.57M | Buy |
161,661
+9,217
| +6% | +$447K | ﹤0.01% | 2181 |
|
|
2025
Q2 | $6.41M | Buy |
152,444
+11,364
| +8% | +$433K | ﹤0.01% | 2225 |
|
|
2025
Q1 | $5.34M | Sell |
141,080
-1,812
| -1% | -$113K | ﹤0.01% | 2244 |
|
|
2024
Q4 | $11M | Buy |
142,892
+5,840
| +4% | +$423K | ﹤0.01% | 1970 |
|
|
2024
Q3 | $7.89M | Buy |
137,052
+89,578
| +189% | +$4.84M | ﹤0.01% | 2151 |
|
|
2024
Q2 | $1.96M | Buy |
47,474
+40,785
| +610% | +$1.93M | ﹤0.01% | 2703 |
|
|
2024
Q1 | $408K | Buy |
+6,689
| New | +$300K | ﹤0.01% | 3105 |
|
|
2023
Q4 | – | Sell |
-1,410
| Closed | -$36.2K | – | 3559 |
|
|
2023
Q3 | $36.2K | Hold |
1,410
| – | – | ﹤0.01% | 3438 |
|
|
2023
Q2 | $24.3K | Sell |
1,410
-7,210
| -84% | -$110K | ﹤0.01% | 3536 |
|
|
2023
Q1 | $105K | Buy |
8,620
+1,262
| +17% | +$53.3K | ﹤0.01% | 3244 |
|
|
2022
Q4 | $263K | Buy |
7,358
+1,746
| +31% | +$54.5K | ﹤0.01% | 3142 |
|
|
2022
Q3 | $192K | Sell |
5,612
-11,609
| -67% | -$578K | ﹤0.01% | 3169 |
|
|
2022
Q2 | $633K | Buy |
17,221
+276
| +2% | +$29.5K | ﹤0.01% | 2973 |
|
|
2022
Q1 | $2.6M | Buy |
16,945
+428
| +3% | +$87.9K | ﹤0.01% | 2555 |
|
|
2021
Q4 | $4.88M | Buy |
16,517
+656
| +4% | +$192K | ﹤0.01% | 2367 |
|
|
2021
Q3 | $4.4M | Buy |
15,861
+7,880
| +99% | +$2.14M | ﹤0.01% | 2433 |
|
|
2021
Q2 | $2.19M | Buy |
7,981
+3,138
| +65% | +$1.12M | ﹤0.01% | 2684 |
|
|
2021
Q1 | $2.38M | Buy |
4,843
+192
| +4% | +$137K | ﹤0.01% | 2612 |
|
|
2020
Q4 | $3.84M | Buy |
+4,651
| New | +$2.71M | ﹤0.01% | 2348 |
|
Other funds holding PRAX
OAG
PA
BBA
VCM
DM
DCM
CAM